Diagnostic Medical Systems (XPAR:ALDMS) COGS-to-Revenue : 0.62 (As of Dec. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Diagnostic Medical Systems COGS-to-Revenue?

Diagnostic Medical Systems's Cost of Goods Sold for the six months ended in Dec. 2024 was €14.41 Mil. Its Revenue for the six months ended in Dec. 2024 was €23.19 Mil.

Diagnostic Medical Systems's COGS to Revenue for the six months ended in Dec. 2024 was 0.62.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Diagnostic Medical Systems's Gross Margin % for the six months ended in Dec. 2024 was 37.85%.

Diagnostic Medical Systems COGS-to-Revenue Historical Data

The historical data trend for Diagnostic Medical Systems's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnostic Medical Systems COGS-to-Revenue Chart

Diagnostic Medical Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.61

0.63

0.61

0.62

0.60

Diagnostic Medical Systems Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial															0.63	0.58	0.66	0.58	0.62

Diagnostic Medical Systems COGS-to-Revenue Calculation

Diagnostic Medical Systems's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	27.677	/	46.069
	=	0.60

Diagnostic Medical Systems's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	14.414	/	23.194
	=	0.62

Diagnostic Medical Systems (XPAR:ALDMS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Diagnostic Medical Systems's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	14.414 / 23.194
	=	37.85 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Diagnostic Medical Systems COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Diagnostic Medical Systems's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnostic Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Diagnostic Medical Systems (XPAR:ALDMS) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

0RIA:UK DMS1:Germany

Address

9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660

Website

https://www.dms.com

Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.

Diagnostic Medical Systems Headlines

No Headlines